Actively Recruiting
Study of Remimazolam Use During Coronary Artery Bypass Surgery to Prevent Postoperative Atrial Fibrillation
Led by Yangzhou University · Updated on 2023-06-06
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Atrial fibrillation AF is a common and serious heart rhythm disorder linked to higher risks of death and illness globally. Postoperative atrial fibrillation POAF is the most frequent secondary form, occurring in about 30% of patients after coronary artery bypass grafting CABG surgery, even with standard beta-blocker treatment. Inflammation plays a key role in POAF development. This trial investigates whether remimazolam, a newly approved sedative with anti-inflammatory properties, can reduce POAF incidence and affect inflammatory and stress markers after CABG surgery. Participants will be randomly assigned to receive either remimazolam or midazolam for general anesthesia during their CABG surgery. The remimazolam group will receive 0.1 mgkg for induction and 0.1 mgkghour for maintenance. The control group will receive 0.1 mgkg midazolam for induction. The study includes an initial open-phase pilot with 50 patients, followed by a double-blind randomized controlled trial to evaluate remimazolams effects on postoperative atrial fibrillation and blood levels of inflammatory and stress factors. During the study, researchers will monitor the occurrence of POAF for seven days after surgery. Blood samples will be taken immediately and 24 hours post-operation to measure inflammatory and stress markers. Myocardial injury markers and hemodynamic parameters will also be assessed. Participant involvement includes anesthesia during surgery and follow-up monitoring, with the trial aiming to provide new evidence on remimazolams role in managing POAF.
CONDITIONS
Brief Title
Remimazolam for Postoperative Atrial Fibrillation
Research Team
X
Xiaojun He, MD, Ph.D.
Z
Zhuan Zhang, MD, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here